FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver by Amélie Bravard et al.
Bravard et al. Cell Communication and Signaling 2014, 12:4
http://www.biosignaling.com/content/12/1/4RESEARCH Open AccessFTO contributes to hepatic metabolism regulation
through regulation of leptin action and STAT3
signalling in liver
Amélie Bravard1, Guillaume Vial1, Marie-Agnès Chauvin1, Yves Rouillé2, Bernard Bailleul3, Hubert Vidal1
and Jennifer Rieusset1,4*Abstract
Background: The fat mass and obesity associated (FTO) gene is related to obesity and type 2 diabetes, but its
function is still largely unknown. A link between leptin receptor-signal transducers and activators of transcription 3
(LepR-STAT3) signalling pathway and FTO was recently suggested in the hypothalamus. Because of the presence of
FTO in liver and the role of LepR-STAT3 in the control of hepatic metabolism, we investigated both in vitro and
in vivo the potential interrelationship between FTO and LepR-STAT3 signalling pathway in liver and the impact of
FTO overexpression on leptin action and glucose homeostasis in liver of mice.
Results: We found that FTO protein expression is regulated by both leptin and IL-6, concomitantly to an induction of
STAT3 tyrosine phosphorylation, in leptin receptor (LepRb) expressing HuH7 cells. In addition, FTO overexpression in vitro
altered both leptin-induced Y705 and S727 STAT3 phosphorylation, leading to dysregulation of glucose-6-phosphatase
(G6P) expression and mitochondrial density, respectively. In vivo, liver specific FTO overexpression in mice induced a
reducetion of Y705 phosphorylation of STAT3 in nuclear fraction, associated with reduced SOCS3 and LepR mRNA levels
and with an increased G6P expression. Interestingly, FTO overexpression also induced S727 STAT3 phosphorylation in
liver mitochondria, resulting in an increase of mitochondria function and density. Altogether, these data indicate that
FTO promotes mitochondrial recruitment of STAT3 to the detriment of its nuclear localization, affecting in turn oxidative
metabolism and the expression of leptin-targeted genes. Interestingly, these effects were associated in mice with
alterations of leptin action and hyperleptinemia, as well as hyperglycemia, hyperinsulinemia and glucose intolerance.
Conclusions: Altogether, these data point a novel regulatory loop between FTO and leptin-STAT3 signalling
pathways in liver cells, and highlight a new role of FTO in the regulation of hepatic leptin action and glucose
metabolism.
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Obesity and type 2 diabetes have reached epidemic
proportions worldwide. Besides environmental factors,
genetic factors largely contribute to the development of
these pathologies. Among the susceptibility genes, the “fat
mass and obesity associated” (FTO) gene may be one of
the molecular determinants linking both pathologies [1].
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stated.appear to affect FTO expression levels, since FTO tran-
scripts containing the risk allele were more abundant than
those containing the wild-type allele [2]. In agreement, we
recently found an increased FTO expression in both
human skeletal muscle [3] and subcutaneous adipose tissue
[4] during type 2 diabetes. Moreover, genetic modulations
of FTO in mice showed that overexpression results in
obesity [5], while inactivation of the gene is protective [6].
Leptin is a multifunctional hormone produced mainly by
adipose tissue, and involved in the regulation of food intake
and energy homeostasis through its central actions [7].
Athough leptin receptors (LepR) are abundantly expressedLtd. This is an Open Access article distributed under the terms of the Creative
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dicating that leptin can exert peripheral actions [8,9]. The
long form receptor (LepRb) regulates intracellular signal-
ling cascades including the JAK-STAT pathway. JAK-
mediated phosphorylation of STAT3 on tyrosine (Y705)
induced its relocation to nucleus, where, as a dimer, it
binds to specific DNA sequences and promotes gene ex-
pression. Interestingly, it was recently demonstrated that
STAT3 could also be phosphorylated on serine residue
(S727), mediating the recruitment of STAT3 to mitochon-
dria where it promotes oxydative metabolism [10,11].
FTO is expressed in many tissues with high abundance
in hypothalamus and liver [12-14]. Whereas confusing data
are found concerning the hypothalamic regulation of FTO
expression by nutritional status [12,13,15,16], one intri-
guing result is that LepRb-STAT3 signalling pathway could
be implicated in FTO regulation by energy restriction in
hypothalamus [12]. In addition, FTO overexpression in-
duced the mRNA levels of STAT3 in the arcuate nucleus
of rat hypothalamus [17]. Consequently, these data suggest
a possible cross-talk between FTO and the LepRb-STAT3
signalling pathway, which could potentially occur in other
tissues, especially in liver where it might play a role in
metabolic control. Indeed, STAT3 has been involved in the
regulation of hepatic gluconeogenesis [18] by repressing
G6P gene expression [19]. Although, very few studies
focused on FTO in liver, it was shown that FTO mRNA is
either not altered by energy restriction in rat liver [12] or
up-regulated by fasting in mice [20] and chicken [21], al-
though FTO protein level appears not modified by fasting
[16]. We therefore concidered that it might be of import-
ance to better understand the potential link between FTO
and LepRb-STAT3 signalling pathway in the control of
hepatic metabolism.
To this aim, we investigated in vitro the potential rela-
tionships between FTO and the LepRb-STAT3 signalling
pathway using human hepatic HuH7 cells, and, we stud-
ied the impact of in vivo FTO overexpression in mice
liver on leptin signalling and glucose homeostasis. Our
study revealed a novel regulatory loop between FTO and
the LepRb-STAT3 pathways and demonstrated a new
role of FTO in the regulation of hepatic leptin action
and glucose metabolism.
Results
FTO expression is regulated by the LepRb-STAT3 signalling
pathway in HuH7 cells
To examine the regulation of FTO expression by LepRb-
STAT3 signalling pathway, we used immortalized HuH7
cells, as an in vitro model of hepatocytes. As they poorly
respond to leptin treatment (Figure 1A), we transfected
them with an expression vector coding for LepRb, and
measured leptin-induced STAT3 phosphorylation to valid-
ate leptin action in LepRb-transfected HuH7 cells. Acuteleptin treatment (5 and 15 minutes) did not significantly
modify the Y705 phosphorylation of STAT3 in LepRb-
transfected cells (Additional file 1: Figure S1A). However,
LepRb overexpression induced STAT3 tyrosine phosphor-
ylation (Y705) upon longer leptin stimulation (Figures 1A
and B). Interestingly, LepRb overexpression per se induced
FTO protein expression (Figures 1A and C), however
3-hour leptin treatment no further increased FTO expres-
sion in LepRb expressing HuH7 cells (Figures 1A and C).
Since IL-6, like leptin, can activate STAT3 pathways [22],
we further investigated whether IL-6 could also affect FTO
expression in control HuH7 cells. Acute IL-6 treatment
(10 ng/ml) had significant but weak effect on Y705 phos-
phorylation of STAT3 (Additonal file 1: Figure S1B).
Indeed, IL-6 treatment induced Y705 phosphorylation of
STAT3 in a time-dependent manner (Figure 2A) concomi-
tantly inducing FTO protein expression with a maximal
effect at 6 hours of treatment (Figure 2B, +70%, p < 0.05),
suggesting that FTO could be a target gene of STAT3 in
hepatocytes. Silencing of STAT3 expression using a specific
siRNA (−50% of STAT3 mRNA levels, p < 0.001) blocked
leptin-induced induction of FTO mRNA levels (leptin ef-
fect on FTO/TBP mRNA: -9% vs +51% in STAT3-silenced
HuH7 cells or in control cells, respectively, p < 0.05),
confirming that FTO is a target gene of STAT3.FTO regulates the LepRb-STAT3 signalling pathway in
HuH7 cells
To investigate the effects of FTO on the LepRb-STAT3
signalling pathway, we then co-expressed LepRb and FTO
in HuH7 cells, and investigated leptin actions on STAT3
phosphorylations. The efficiency of the co-transfections
was confirmed by the increased FTO protein levels
(Figure 3A), as well as by the ability of leptin to phosphor-
ylate STAT3 on Y705 (Figure 3B). Leptin significantly in-
creased FTO protein expression in control co-transfected
cells, but not in cells overexpressing FTO (Figure 3A).
Importantly, FTO overexpression reduced Y705 STAT3
phosphorylation by leptin by 1.9 fold, compared to leptin-
stimulated control co-transfected cells (Figure 3B). In
addition, leptin response on S727 STAT3 phosphorylation
was also affected by FTO overexpression, since leptin
could not decrease S727 STAT3 phosphorylation in pres-
ence of FTO, as in control conditions (Figure 3C). These
data indicate thus that FTO interacts with leptin-induced
STAT3 phosphorylation both on tyrosine 705 and serine
727 residues in HuH7 cells. Another pathway regulated
by LepRb is the phosphorylation of PKB. Then, we inves-
tigated whether FTO impact also on leptin-induced PKB
phosphorylation (S473) in HuH7 cells. As shown on
Figure 3D, leptin induced PKB phosphorylation in
LepRb-transfected cells (3 fold, p < 0,005), and FTO


























































Figure 1 Leptin regulates STAT3 signalling and FTO expression in HuH-7 cells. HuH7 cells were transfecting with pcDNA3-LepRb and empty
pcDNA3 vectors for 36 hours. Cells were then serum starved for 16 hours before leptin stimulation (100 ng/mL) during the indicated periods.
A) Representative Western Blots of pSTAT3(Y705) and total STAT3, as well as FTO and actin proteins, in HuH-7 cells expressing LepRb treated
with leptin (100 ng/mL). B-C) Quantitative analysis of both Y705 phosphorylation of STAT3 B) and FTO expression C) in 3-hour leptin treated
transfected HuH7 cells, showing that B) leptin increases Y705 phosphorylation of STAT3 in LepRb expressing HuH7 cells, and that C) the
overexpression of LepRb induces FTO protein levels. Data are means ± SEM (n = 6/group). *p < 0.05 compared to control transfected cells.
LepRb: leptin receptor; STAT3: signal transducer and activator of transcription 3; FTO: fat-mass and obesity associated gene.
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overexpression on leptin-regulated downstream steps of
STAT3. STAT3 tyrosine phosphorylation is required for
dimer formation, nuclear translocation, and thus for the
DNA binding activity of this transcriptional regulator
[23]. Among STAT3-regulated genes, G6P gene is
repressed by STAT3 in HuH-7 cells [19]. Thus, we
measured FTO overexpression effect on G6P expres-
sion. As expected, one hour of leptin treatment re-
pressed the transcription of G6P gene in control condition
(Figure 4A). However, G6P mRNA levels were signifi-
cantly increased in basal conditions of FTO overex-
pressing HuH7 cells and leptin-induced repression of
G6P transcription was totally abolished (Figure 4A).
On the other hand, S727 STAT3 phosphorylation has
been shown to favor translocation of STAT3 to the
mitochondria and to regulate mitochondrial activity
[10]. Therefore, we investigated the consequence of
FTO-mediated alteration of S727 STAT3 phosphoryl-
ation on cellular mitochondrial density in co-transfected
HuH7 cells. As shown in Figure 4B, FTO expression
significantly increased the mitochondrial DNA/nuclear
DNA ratio in co-transfected HuH7 cells (p < 0.05).
These finding suggest that FTO expression in liver
cells could alter leptin-induced Y705 and S727 STAT3phosphorylations impacting on metabolic gene expres-
sion and mitochondrial density.
Disruption of STAT3 signalling in liver of mice
overexpressing FTO
To determine the physiological relevance of these observa-
tions in vivo, we investigated the impact of liver-targeted
FTO expression in mice. We infected male C57BL/6 mice
by retroorbital injections of recombinant adenovirus cod-
ing for FTO or GFP (as control), and followed STAT3
phosphorylation in both nuclear and mitochondrial liver
fractions. As shown in Additional file 1: Figure 2, under
this experimental setting, FTO was specifically overex-
pressed in liver, since no change of FTO mRNA levels was
observed in epididymal adipose tissue and hypothalamus
of Ad-FTO infected mice compared to Ad-GFP mice. In
agreement with in vitro data, we found a decreased content
of nuclear STAT3 phosphorylated on Y705 (normalized by
the nuclear protein SET7) in nuclear fractions of FTO-
infected mice compared to GFP-infected mice (Figure 5A,
-94%, p < 0.01). Moreover, we found a significant increase
of S727 STAT3 phosphorylation (normalized by VDAC1
protein) in mitochondrial fractions of FTO-infected
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Figure 2 IL-6 regulates STAT3 signaling and FTO expression in
HuH7 cells. HuH7 cells were depleted for 16 hours of serum and
treated with IL-6 (10 ng/ml) during different times. A) Representative
Western blots and quantitative analysis of Y705 phosphorylation of
STAT3 in HuH-7 cells treated with IL-6 (10 ng/ml), showing that IL-6
stimulates tyrosine phosphorylation of STA3 in a time-dependant
manner in HuH7 cells expressing LepRb. B) Representative Western
blots and quantitative analysis of FTO expression in HuH7 cells
treated with IL-6, showing that IL-6 stimulates FTO protein levels in
HuH7 cells expressing LepRb. Data are means ± SEM (n = 4/group).
*p < 0.05 compared to untreated cells.
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Then we measured the effects of FTO overexpression on
downstream events of activated STAT3 in mice liver. In
agreement with a decreased content of Y705 STAT3
phosphorylation upon FTO overexpression, we found a
decrease of SOCS3 mRNA levels and an increase of G6P
expression in liver of Ad-FTO mice (Figure 5C). Fur-
thermore, the mRNA levels of the transcription factor
FOXO1α was significantly increased whereas only a ten-
dency was observed for PEPCK and PGC1α, following
FTO overexpression (Figure 5C), suggesting that FTO
may participate in the control of neoglucogenic genes
expression by interacting with STAT3 in liver. We also
found that the mtDNA/nuclear DNA ratio was markedlyincreased (2.5 fold, p < 0.05) in liver of Ad-FTO mice
(Figure 6A) in agreement with FTO-induced increase of
S727 STAT3 phosphorylation. Furthermore, POLG1 and
POLG2 and TFAM, key genes implicated in mito-
chondrial replication were also induced in liver of
Ad-FTO mice (Figure 6B). Moreover, the mRNA
levels of the mitochondria-encoded gene COX3 were
increased in liver of Ad-FTO mice (Figure 6B). We
then measured oxygen consumption by isolated mito-
chondria from liver of infected mice. As shown in
Figure 6C, FTO overexpression significantly increased
oxygen consumption stimulated by either octanoyl-
or palmitoyl-CoA (+18,2% and +15,5%, respectively,
p < 0,05), whereas the respiration under glutamate/
malate or succinate substrates were not significantly
modified. Altogether, these results confirmed in vivo
that FTO may regulate both hepatic neoglucogenenic
gene expression and oxidative metabolism by inter-
acting with the STAT3 signaling pathways.
FTO overexpression alters leptin action and glucose
homeostasis in mice
We found that Ad-FTO mice have increased circulat-
ing leptin concentration in the fasting state when
compared to Ad-GFP mice (Table 1), suggesting com-
pensatory mechanism against a state of leptino-
resistance. In agreement, the mRNA levels of LepR
and SOCS3, but not STAT3, were decreased in liver
overexpressing FTO (Figure 5B). To verify whether
leptin action was reduced in vivo, we investigated the
effect of FTO on leptin-induced PKB phosphorylation.
For that, we infused leptin to fasted infected C57BL/6
mice and measured the repercussion on the phos-
phorylation of PKB 30 minutes after treatment. As
shown on Figure 7A, leptin induced a 3-fold induc-
tion of S473 phosphorylation of PKB in Ad-GFP mice
and this effect was lost following FTO overexpression,
in agreement with in vitro data. Although this was
due in part to an increase of basal PKB phosphoryl-
ation (Figure 7A), this result indicated that FTO over-
expression was able to prevent leptin action in vivo
in mice liver.
We then verified whether FTO-mediated disruption
of leptin-STAT3 signalling could alter glucose homeo-
stasis in mice. We found that both fasting glycemia
and insulinemia were significantly higher in Ad-FTO
mice compared to Ad-GFP mice (Table 1). Moreover,
glucose tolerance test revealed that Ad-FTO mice
were glucose intolerant (Figure 7B). However, despite
hyperglycemia all along the test, the response of gly-
cemia to insulin injection (insulin tolerance test) was
similar between both mice (Figure 7C), suggesting
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Figure 3 FTO regulates the LepRb-STAT3 signalling pathway in co-transfected HuH7 cells. HuH7 cells were co-transfecting with both
LepRb and FTO vectors (empty vector as control) for 36 hours. Cells were then serum starved for 16 hours before three-hour leptin stimulation
(100 ng/mL). A) Representative Western blots and quantitative analysis of FTO expression in co-transfected HuH7 cells, validating the FTO
overexpression. B) Representative Western blots and quantitative analysis of pSTAT3(Y705) and total STAT3 in co-transfected HuH7 cells, showing
that FTO represses the leptin-induced STAT3 tyrosine phosphorylation. C) Representative Western blots of pSTAT3(S727) and total STAT3 in
co-transfected cells, showing that FTO represses the leptin-mediated reduction of serine phosphorylation of STAT3. D) Representative Western
blots and quantitative analysis of pPKB(S473) and PKB proteins in co-tranfected HuH7 cells, showing that FTO represses the leptin-induced PKB
phosphorylation. Data are means ± SEM (n = 3-6/group). *p < 0.05 compared to untreated control cells. #p < 0.05 compared to treated control cells.
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The regulation and functions of FTO in liver are
largely unknown. In this study we report a new role
of FTO as a regulator of leptin-STAT3 pathway in he-
patocytes using both in vitro and in vivo approches.
We demonstrate that FTO overexpression disturbs
LepRb-STAT3 signalling pathway with both a reduc-
tion of leptin-induced Y705 phosphorylation and an
induction of S727 phosphorylation of STAT3, whichis normally repressed by leptin. The effect on tyrosine
phosphorylation affects STAT3 translocation to the
nucleus and regulation of leptin target genes. The
effect on STAT3 S727 phosphorylation favors its
translocation to the mitochondria and increases mito-
chondria density and function. As a consequence of
this dual effect on leptin-induced STAT3 phosphoryl-






















































Figure 4 FTO regulates downstream events of activated STAT3
in co-transfected HuH7 cells. HuH7 cells were co-transfecting with
both LepRb and FTO vectors (empty vector as control) for 36 hours.
Cells were then serum starved for 16 hours before three-hour leptin
stimulation (100 ng/mL). A) Effect of FTO overexpression on G6P
mRNA levels of leptin-stimulated co-transfected HuH7cells, measured
by real-time RT-PCR and expressed relative to untreated control
co-transfected HuH7 cells. B) Effect of FTO overexpression on
mtDNA amount of co-transfected HuH7 cells. Data are means ± SEM
(n = 6/group). *p < 0.05 compared to untreated control cells A) or to
mock transfected cells B). G6P: Glucose 6 phosphatase. TBP: TATA
box binding protein.
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http://www.biosignaling.com/content/12/1/4Leptin, as other cytokines like IL-6, activate the tyro-
sine phosphorylation of STAT3 via specific membrane
receptors, inducing its translocation into the nucleus
where it regulates gene expression. Whereas LepRb is
most abundantly expressed in the brain, it is also present
in peripheral tissue, in particular in liver [8,24,25]. A
previous study has challenged the presence of functional
LepRb in hepatocytes [26], whereas other studies state
that leptin was active on hepatocytes [27,28]. In our
study, we demonstratedd that leptin has not only an ac-
tion on LepRb-expressing HuH7 cells and in mice liver,
but also in rat primary hepatocytes (Additional file 1:
Figure 3A and B), validating that leptin has really a
metabolic role in hepatocytes. Nevertheless, we observed
that rather long treatment with leptin or IL-6 are re-
quired to activate the LepRb-STAT3 pathway. Conse-
quently, we cannot exclude that an indirect or secondary
effect in HuH7 cells, such as the production andsecretion of other factors, participate to the leptin/IL-6-
mediated activation of STAT3 in 3 hour-treated HuH7
cells. Thus, we propose that leptin likely acts on hepato-
cytes through both direct and indirect mechanisms. In
addition to increase STAT3 tyrosine phosphorylation, we
further demonstrated that leptin reduced the serine
phosphorylation of STAT3 in LepRb-transfected cells
HuH7 cells. This data are in agreement with a recent
study demonstrating that leptin receptor-free tumor cells
display increased STAT3 serine phosphorylation on resi-
due S727, and preserved mitochondrial function [29]. As
both phosphorylation sites on STAT3 are in close prox-
imity (Y705 and S727), it is possible that pS727-STAT3
enhances the dephosphorylation of pY705, as recently
suggested [11], or that the phosphorylation of one
residue hinder the phosphorylation of the other ones.
Consequently, we cannot exclude that the reduction of
pS-STAT3 phosphorylation in response to leptin was a
consequence of the increase of leptin-mediated pY-
STAT3 phosphorylation in HuH7 cells.
We found in HuH7 cells that leptin and IL-6 induce
FTO expression and that silencing of STAT3 inhibits
leptin-mediated regulation of FTO, suggesting that FTO
gene can be directly controlled by STAT3. This finding
confirms in liver cells previous studies demonstrating
that FTO expression could be regulated by nutritional
status via LepRb-STAT3 signalling pathway in hypothal-
amus [12]. It is also in line with the observation that
FTO mRNA levels were positively correlated with G6P
and PEPCK expression in liver [20].
More interestingly, we demonstrated both in vitro and
in vivo that FTO impacts LepR-STAT3 pathway via a
fine control of STAT3 phosphorylation, as well as PKB
pathway. Concerning STAT3, FTO overexpression in
liver of mice decreases Y705 STAT3 phosphorylation in
nucleus associated with an increased mitochondrial S727
STAT3 phosphorylation and reduced leptin-regulated
phosphorylation of STAT3 on both sites in LepRb ex-
pressing HuH7 cells. This suggest that FTO favors
STAT3 mitochondrial translocation at the expense of
nuclear localization in liver, leading to an upregulation
of neoglucogenic genes and to an increase of mitochon-
drial density and function in liver of mice overexpressing
FTO. Consequently, these data are in agreement with re-
cent studies showing that the preferential localization of
S727 phosphorylated STAT3 into mitochondria is associ-
ated with an increase of mitochondria respiration
[10,30], and further suggest that FTO may regulate en-
ergy metabolism in the liver likely though mitochondrial
STAT3 localization. These effects have detrimental
in vivo consequences both on leptin action and glucose
homeostasis. Indeed, liver FTO overexpression induced
an inhibition of leptin-induced PKB phosphorylation, a
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Figure 5 Overexpression of FTO in liver of mice disruptsSTAT3 pathway. FTO was overexpressed in liver of mice by adenoviral infection
using a recombinant adenovirus encoding human FTO or GFP (as control) proteins for 10 days (2.108ifu/g of body weight). A) Representative
Western blots and quantitative analysis of pSTAT3(Y705) and SET7 proteins in nuclear fractions of liver infected with a recombinant adenovirus
encoding human FTO or GFP (as control) proteins for 10 days. Controls with a marker of mitochondrial fractions illustrate that pS-STAT3 is nor
present in nucleus fractions. B) Representative Western blots and quantitative analysis of pSTAT3(S727) and VDAC in mitochondrial fractions of
infected liver. Controls with a marker of nucleus fractions illustrate that pY-STAT3 is nor present in mitochondrial fractions. C) mRNA levels of G6P,
PEPCK, PGC1α and FOXO1α determined by real-time PCR in liver of Ad-GFP and Ad-FTO mice and expressed relative to Ad-GFP mice Data are
means ± SEM (n = 4/group for A and n = 6/group for B). *p < 0.05 compared to Ad-GFP mice.
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http://www.biosignaling.com/content/12/1/4LepR, G6P and FOXO1). Furthermore, Ad-FTO mice
developed hyperleptinemia, indicating that FTO inhibits
leptin action, and mimic a state of leptin resistance.
Interestingly, mitochondrial respiration is increased in
liver of leptin deficient ob/ob mice [31], and leptin was
reported to reduce hepatic metabolism in ob/ob mice
via changes in mitochondria function, structure, and
protein levels [32], suggesting that the mitochondrial ef-
fects of FTO could be a consequence of FTO-mediated
inhibition of leptin action. In addition, Ad-FTO mice de-
velop hyperglycemia, hyperinsulinemia and glucose in-
tolerance, pointing thus a novel important role of FTO
in the regulation of glucose metabolism. These data are in
agreement with previous data showing that FTO-deficient
mice show alterations of energy homeostasis [6] andthat hepatic FTO expression is regulated by metabolic
state [20]. Furthermore, the data are supported by
STAT3 manipulation models of mice showing that liver
specific knock-out induces neoglucogenic gene expres-
sion and hepatic insulin resistance [18], whereas liver
specific overexpression of STAT3 reduces glycemia,
insulinemia and neoglucogenic gene expression [19].
FTO may therefore be a novel regulator of STAT3 meta-
bolic actions in liver cells.
The exact function of FTO remains unknown.
Recombinant FTO protein catalyses the Fe(II)-and
2-oxoglutarate-dependant demethylation of RNA [14] and
N6-methyl-adenosine [33]. This demethylation could
stabilize the target mRNA and increase its expresion








































































Figure 6 FTO overexpression in liver of mice regulates mitochondrial density and funtion. Liver of mice were infected with recombinant
adenovirus encoding human FTO or GFP (control) proteins for 10 days (2.108ifu/g of body weight). A) Effect of FTO on mtDNA quantity,
calculated as the ratio of COX1 to cyclophilin A DNA levels, and measured by real-time PCR in the liver of infected mice. B) Effect of FTO on the
mRNA levels of POLG1, POLG2, SSBP1, TFAM, NRF1, NRF2, COX3 measured by real-time PCR in the liver of Ad-GFP and Ad-FTO mice. C) Effect of
FTO on oxygen consumption of mitochondria isolated from liver of Ad-GFP and Ad-FTO mice. Data are means ± SEM (n = 5/group). *p < 0.05
compared to GFP infected mice.
Table 1 Metabolic paramaters of Ad-GFP and Ad-FTO
mice after an overnight fasting
Ad-GFP mice Ad-FTO mice p value
Body weight (g) 22.5 ± 0.5 23.8 ± 0.5 NS
Liver weight (g) 1.6 ± 0.06 1.5 ± 0.06 NS
Fasting glycemia (mg/dl) 86 ± 5 110 ± 3 0.002
Fasting insulinemia (ng/ml) 0.22 ± 0.03 0.50 ± 0.01 0.02
Fasting leptinemia (ng/ml) 0.5 ± 0.1 13 ± 0.3 0.03
FTO was overexpressed in liver of mice by adenoviral infection using a
recombinant adenovirus encoding human FTO or GFP (as control) proteins for
10 days (2.108ifu/g of body weight). Blood was removed by reorbital punction
on isofluran-anesthesized mice, after an overnight fasting. Data are means ± SEM
(n = 8/group).
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were associated with reduced ghrelin mRNA N6-
methyladenosine methylation and increased ghrelin
expression [34], confirming in vivo a role of FTO in
methylation process. In our study, the mechanisms by
which FTO controls the LepRb-STAT3 signalling
pathway and leptin action is unknown, and further
studies are required to determine whether methyla-
tion processes are implicated. We can only speculate
that if it occurs, it probably does not affect LepR,
SOCS3 or STAT3 mRNAs directly since both LepR
and SOCS3 expression is down-regulated, whereas
STAT3 expression is not affected by FTO overexpres-
sion. Nevertheless, our data indicate that FTO could
AP-PKB (Ser473)
PKB































































































































Figure 7 FTO overexpression in liver of mice affects leptin action and glucose homeostasis. Liver of mice were infected with recombinant
adenovirus encoding human FTO or GFP (control) proteins for 10 days (2.108ifu/g of body weight). A) After an overnight fasting, infected mice
were treated by ip injection with leptin (1 μg/g) for 30 minutes. Representative Western blots and quantitative analysis of pPKB(S473) and PKB
proteins in liver of leptin-treated infected mice. Note that four parts of a same gel were shown. B) Glucose tolerance test performed after 6 hours
of fasting on infected mice and corresponding quantitative analysis of area under curves. B) Insulin tolerance test performed after 6 hours of
fasting on infected mice and corresponding quantitative analysis of area under curves. Data are means ± SEM (n = 3/group for A and n = 8/group
for B-C). *p < 0.05 compared to GFP infected mice.
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aggreement, FTO expression is increased in liver of a
rat model of nonalcoholic fatty liver disease [35], and
FTO overexpression increased oxydative stress and
lipogenesis in L02 cells [35] and myotubes [3]. In addition,
as leptin was shown to regulate immunoreaction in liver,
playing a critical role to hyperreactivity against endo-
toxin during NASH progression [36], further studies
are required to determine whether FTO could impact
this pathway. Finally, it should be noted that S727
STAT3 phosphorylation is needed for constitutive
activation of STAT3 and cell invasion in various hu-
man cancers [37,38]. Therefore, interaction between
FTO and STAT3 may suggest potential implication of
FTO in cancer development, as it has already been
suggested [39].Conclusions
In conclusion, our study highlights a new function of
hepatic FTO in the regulation of leptin action and the
control energy metabolism via interactions with STAT3
signalling (Figure 8). Actions of FTO could involve a
recruitment of S727-phosporylated STAT3 into mito-
chondria, at the expense of nuclear localization,
impacting subsequently both mitochondrial oxida-
tive metabolism and neoglucogenic gene expression.
Because it is well known that leptin and STAT3 are
important players of metabolic diseases, our results
suggest that the role of FTO in the liver should be
taken into consideration for the understanding of the
metabolic regulations and that FTO polymorphisms












































Figure 8 Model of FTO regulation of leptin action and glucose homeostasis through the LepRb-STAT3 signaling pathway. A) The
binding of leptin to its receptor triggers the activation of JAK2 and the phosphorylation of STAT3 on a tyrosine residue (Y705). This modification
causes the STAT3 protein to relocate to the nucleus, where as a dimer, it regulates gene expression (upregulation of both SOCS3 and LepR and
reduction of G6P). Our data further suggest that FTO could be a STAT3-upregulated gene in hepatocytes. B) FTO overexpression reduces Y705
STAT3 phosphorylation, reducing its nuclear translocation and leading to a downregulation of both SOCS3 and LepRb and an upregulation of
G6P mRNA levels. Just to opposite, FTO overexpression induces S727 phosphorylation of STAT3, favorizing its mitochondrial localization, where it
induces mitochondrial density and function. All these effects are associated in vivo with hyperleptinemia, hyperglycemia, hyperleptinemia and
glucose intolerance. Altogether, these data indicate that FTO controls leptin action and glucose metabolism in liver.
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Mouse
Animal studies were performed in accordance with the
French guidelines for the care and used of animals and
were approved by our regional ethic committee. Eight
week-old male C57BL/6 mice (Harlan) were housed
in controlled environment. Recombinant adenovirusesencoding for FTO or GFP proteins (Ad-FTO and Ad-GFP,
respectively) were injected retroorbitally in mice (2.108 in-
fection forming units (ifu)/g of body weight), in order to
over-express proteins specifically in liver. Glucose and
insulin tolerance test were done respectively on day 7 and
9 after adenoviral infection. During these tests, glycemia
were followed every 15 minutes after intraperitoneally
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(0.75 mUI/g of body weight). On day 10, blood was col-
lected from animals by retroorbital punction under iso-
fluran anesthesia, and mice were killed by cervical
dislocation. Blood glucose levels were measured using a
glucometer (Roche Diagnostics). Serum levels of insulin
and leptin were determined using murine ELISA kits
(ALPCO).
Primary hepatocytes
Rat primary hepatocytes were isolated in the presence of
collagenase according to the method of Berry and Friend
[40], modified by Groen et al. [41].
Constructions
The cDNA sequence encoding full-length human FTO was
generated as previously described [3]. Recombinant adeno-
viral genome encoding human FTO was generated by
homologous recombination and amplified as described pre-
viously [3]. The plasmid encoding an HA-tagged murine
LepRb was generated as previously described [42].
Cell culture and transfection
HuH7 cells were grown in Dulbecco modified Eagle’s
medium (PAA) supplemented with 10% fetal bovine
serum. Cells were transfected with 1 μg expression plas-
mids for the FTO gene or for the LepRbgene (pcDNA3-
FTO and pCIneo-LepRb, respectively), using EXGEN
500 transfecting reagent (Euromedex). In cotransfection
experiments, cells received at the same time 1 μg of both
vectors. An empty vector was used as control in each ex-
periment. HuH7 cells were then used for treatments 48
hours post-transfection. Treatments included leptin
(Labomics, 100 ng/ml) and IL-6 (Sigma, 10 ng/mL) in-
cubations after a 16 hour serum depletion.
Total RNA preparation and quantification of messenger
RNAs
Total RNA from tissues or cell cultures were purified using
the TRI Reagent Solution (Sigma). mRNA levels were mea-
sured by reverse-transcription followed by real time quanti-
tative PCR using a Rotor-Gene 6000 (Corbett Research), as
previously described [3]. Primers are listed in Additional file
2: Table S1. Values were normalized using HPRT or TBP,
which were similar among conditions.
Western blot analysis
Tissues lysis and both separation and revelation of proteins
were performed as described previously [3]. The primary
antibodies used for protein detection are: STAT3 (Cell Sig-
naling, #4904), Phospho-STAT3 (Tyr705) (Cell signaling,
#9145), Phospho-STAT3 (Ser727) (Cell signaling, #9134),
FTO (Abcam, ab65366), Actin (Sigma, A5060), SET7/9
(Santa Cruz, sc-56774), VDAC1/Porin (Abcam, ab14734).Subcellular fractionation
Liver was homogenised in isolation buffer (Mannitol
210 mM, Saccharose 70 mM, Tris 50 mM, EDTA
10 mM and BSA 0.5%, pH = 7.4) using a teflon pestle,
and centrifuged 10 minutes at 800 g. The pellet was kept
for further nuclei isolation whereas the supernatant was
centrifuged 10 minutes at 8000 g for mitochondria isola-
tion, as previouly described [43]. The pellet of mitochon-
dria was resuspended in isolation buffer, centrifuged a
second time 10 minutes at 8000 g and resuspended in
isolation buffer. For nuclei isolation, the pellet from the
first centrifugation was resuspended in a hypertonic buf-
fer (Hepes 10 mM, NaCl 0.42 M, MgCl2 1.5 mM, Gly-
cerol 2.5%, EDTA 1 mM, EGTA 1 mM, DTT 1 mM,
protease inhibitors cocktail 1X, pH = 7.4) and centri-
fuged for 30 min at 100 000 g in order to get nuclear
extract in supernatant.
Measurement of mitochondrial respiration on isolated
mitochondria
Mitochondrial respiration rates were measured at 30°C
on freshly isolated liver mitochondria using a closed-
thermostated oxygraph (Stratkelvin, UK). Different
substrates were used: glutamate 5 mM+malate 2.5 mM
as complex 1 substrates; succinate 5 mM+ rotenone
5 μM as a complex 2 substrates with inhibition of com-
plex 1 by rotenone; octanoyl-carnitine (110 μM) or
palmitoyl-carnitine (55 μM) in presence of 1 mM mal-
ate, as β-oxydation substrates. State 3 was measured in
the presence of respiratory substrates after the addition
of 1 mM ADP and state 4 was measured after the
addition of oligomycin (2 μg/mL).
Mitochondrial DNA analysis
The extraction of total DNA and the measurement of
mitochondrial DNA (mtDNA) content by real time PCR
was performed as previously described [43].
Statistical analyses
All data are represented by means ± SEM. Statistical sig-
nificance was determined using student unpaired t test.
The threshold for significance was set at p < 0.05.
Additional files
Additional file 1: Figure S1. Acute leptin and IL-6 treatments on
pY-STAT3 phosphorylation in HuH7 cells. Figure S2. Validation of the
specific overexpression of FTO in liver of infected mice. Figure S3. Effect
of leptin on pY-STAT3 phosphorylation and G6P expression in rat primary
Hepatocytes.
Additional file 2: Table S1. Sequences of primer.
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